Small but sophisticated medical device market. Imports supply most of the market. Other medical devices and diagnostic imaging have the largest market shares. High per capita spending in the Middle East Africa region. High single-digit market CAGR driven by the National Health Strategy.

Second smallest market in the Asia Pacific (APAC) region. Per capita spending is one of the lowest in the world. Market growth will be below average for the region. Other medical devices and consumables have the largest market shares. The market is heavily reliant on imports. Domestic manufacturing is concentrated in Sialkot and centres mainly around steel surgical instruments and other hand held medical devices. Production is of a high quality but mostly destined for export.

Largest medical device market in the Central & Eastern Europe (CEE) region. Per capita spending is low for the CEE region.Market will record moderate growth in US dollar terms. Other medical devices and diagnostic imaging have the largest market shares. The government has increased the number of medical devices subject to import restrictions, which could negatively impact the sales of foreign manufacturers. Import shares may fall by 2020, in accordance with the Ministry of Industry and Trade's import substitution plan, which aims to reduce the import shares of 111 groups of medical devices. The greatest opportunities exist around the major cities of Moscow and St Petersburg, where most companies are based and per capita incomes are well above the national average.

Fourth smallest market in the Middle East and Africa (MENA) region. Per capita spending of less than USD1 is the lowest in the MENA region. Moderate US dollar 2017-2022 CAGR, higher growth in local currency terms due to naira weakness Consumables is the largest product area. The orthopaedics & prosthetics market is particularly under-developed. Most requirements need to be imported as domestic production is negligible. Despite efforts to achieve universal health coverage and raise investment levels, the health sector is massively underfunded.

Small, underfunded market. Per capita medical device spending is below average for the MEA region. Market growth well above the global average forecast. Public hospital network is likely to be major purchaser due to out of date equipment. Universal health insurance system being implemented. Private sector set for a period of renewed growth as a result of moves to open up private clinics to commercial investors. Imports supply over 90% of the market. Capital investment projects rely on finance from sources outside Morocco. Training medical staff being prioritised.

Oil wealth has facilitated development of sophisticated healthcare system. The largest medical device market in the Middle East and Africa region. Market size reduced and market forecast revised upwards in December 2017. Reliant on imports, primarily from the US and Western Europe. Other medical devices and consumables have large market shares. improving regulations, which are approaching standards seen in developed states. Limited direct presence of multinational companies.

Eighth largest Central & Eastern European (CEE) market. Per capita spending is below the CEE average. The market will grow by a high US dollar CAGR. • Other medical devices and diagnostic imaging have the largest market shares. There is little local production, so much of the market is largely reliant on imports. The health sector is historically underdeveloped, poorly funded and poorly managed. Growing private healthcare sector. Continued World Bank support should maintain progress in developing the health sector. One of the CEE region's most populous countries.

Small market in the Middle East and Africa region; it ranks outside the top-10. • Average per capita expenditure in the region. • Moderate market growth. • After other medical devices, diagnostic imaging has the largest market share. • Market heavily reliant on imports, particularly from Europe, the US and China. • Positive demographic drivers, including ageing population and increasing chronic diseases. • Healthcare infrastructure developments will also encourage market growth.